Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

November 01, 1989; Volume 36,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Akiyama, S

    1. You have access
      Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

B

  1. Beavo, J A

    1. You have access
      Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
      P G Gillespie and J A Beavo
      Molecular Pharmacology November 1989, 36 (5) 773-781;
  2. Blättler, W A

    1. You have access
      Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;
  3. Blaustein, M P

    1. You have access
      Rat brain dendrotoxin receptors associated with voltage-gated potassium channels: dendrotoxin binding and receptor solubilization.
      R G Sorensen and M P Blaustein
      Molecular Pharmacology November 1989, 36 (5) 689-698;
  4. Blumer, J L

    1. You have access
      Role of microtubule assembly in phenytoin teratogenic action in the sea urchin (Arbacia punctulata) embryo.
      S Estus and J L Blumer
      Molecular Pharmacology November 1989, 36 (5) 708-715;
  5. Breuer, E

    1. You have access
      Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

C

  1. Chiang, P K

    1. You have access
      Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;
  2. Collier, K

    1. You have access
      Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;
  3. Colman, P D

    1. You have access
      Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
      R G Moran, P D Colman and T R Jones
      Molecular Pharmacology November 1989, 36 (5) 736-743;

D

  1. de Carvalho, M S

    1. You have access
      Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;
  2. Diamond, I

    1. You have access
      Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;
  3. Didsbury, J

    1. You have access
      Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;

E

  1. Eling, T

    1. You have access
      Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates.
      D Thompson and T Eling
      Molecular Pharmacology November 1989, 36 (5) 809-817;
  2. Estus, S

    1. You have access
      Role of microtubule assembly in phenytoin teratogenic action in the sea urchin (Arbacia punctulata) embryo.
      S Estus and J L Blumer
      Molecular Pharmacology November 1989, 36 (5) 708-715;

F

  1. Faulkner, D J

    1. You have access
      Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;
  2. Funae, Y

    1. You have access
      Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

G

  1. Gillespie, P G

    1. You have access
      Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
      P G Gillespie and J A Beavo
      Molecular Pharmacology November 1989, 36 (5) 773-781;
  2. Glaser, K B

    1. You have access
      Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;
  3. Goldmacher, V S

    1. You have access
      Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;
  4. Gordon, A S

    1. You have access
      Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;
  5. Gordon, R K

    1. You have access
      Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

H

  1. Hinton, D E

    1. You have access
      Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart.
      J J Stegeman, M R Miller and D E Hinton
      Molecular Pharmacology November 1989, 36 (5) 723-729;

I

  1. Imaoka, S

    1. You have access
      Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

J

  1. Jacobs, R S

    1. You have access
      Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;
  2. Jones, T R

    1. You have access
      Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
      R G Moran, P D Colman and T R Jones
      Molecular Pharmacology November 1989, 36 (5) 736-743;

K

  1. Kato, R

    1. You have access
      Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;
  2. Kernan, M R

    1. You have access
      Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
      K B Glaser, M S de Carvalho, R S Jacobs, M R Kernan and D J Faulkner
      Molecular Pharmacology November 1989, 36 (5) 782-788;
  3. Kikuchi, H

    1. You have access
      Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;
  4. Krueger, B K

    1. You have access
      Batrachotoxin and alpha-scorpion toxin stabilize the open state of single voltage-gated sodium channels.
      M E O'Leary and B K Krueger
      Molecular Pharmacology November 1989, 36 (5) 789-795;
  5. Kuwano, M

    1. You have access
      Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

L

  1. Lambert, J M

    1. You have access
      Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;
  2. Lee, W

    1. You have access
      Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
      W Lee and B B Wolfe
      Molecular Pharmacology November 1989, 36 (5) 749-757;
  3. Longabaugh, J P

    1. You have access
      Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;
  4. Lopez, L

    1. You have access
      Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

M

  1. McIntyre, G

    1. You have access
      Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;
  2. Miller, L G

    1. You have access
      Chronic clonazepam administration decreases gamma-aminobutyric acidA receptor function in cultured cortical neurons.
      L G Miller, R B Roy and C L Weill
      Molecular Pharmacology November 1989, 36 (5) 796-802;
  3. Miller, M R

    1. You have access
      Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart.
      J J Stegeman, M R Miller and D E Hinton
      Molecular Pharmacology November 1989, 36 (5) 723-729;
  4. Miller, R J

    1. You have access
      Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines.
      I J Reynolds and R J Miller
      Molecular Pharmacology November 1989, 36 (5) 758-765;
  5. Moran, R G

    1. You have access
      Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
      R G Moran, P D Colman and T R Jones
      Molecular Pharmacology November 1989, 36 (5) 736-743;
  6. Morgan, E T

    1. You have access
      Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin.
      E T Morgan
      Molecular Pharmacology November 1989, 36 (5) 699-707;
  7. Murayama, N

    1. You have access
      Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;

N

  1. Nagy, L E

    1. You have access
      Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

O

  1. O'Leary, M E

    1. You have access
      Batrachotoxin and alpha-scorpion toxin stabilize the open state of single voltage-gated sodium channels.
      M E O'Leary and B K Krueger
      Molecular Pharmacology November 1989, 36 (5) 789-795;
  2. Ozawa, H

    1. You have access
      Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment.
      H Ozawa and M M Rasenick
      Molecular Pharmacology November 1989, 36 (5) 803-808;

P

  1. Padilla, F N

    1. You have access
      Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;

R

  1. Rasenick, M M

    1. You have access
      Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment.
      H Ozawa and M M Rasenick
      Molecular Pharmacology November 1989, 36 (5) 803-808;
  2. Reynolds, I J

    1. You have access
      Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines.
      I J Reynolds and R J Miller
      Molecular Pharmacology November 1989, 36 (5) 758-765;
  3. Roy, R B

    1. You have access
      Chronic clonazepam administration decreases gamma-aminobutyric acidA receptor function in cultured cortical neurons.
      L G Miller, R B Roy and C L Weill
      Molecular Pharmacology November 1989, 36 (5) 796-802;

S

  1. Shimada, M

    1. You have access
      Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;
  2. Smejkal, R M

    1. You have access
      Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
      R K Gordon, E Breuer, F N Padilla, R M Smejkal and P K Chiang
      Molecular Pharmacology November 1989, 36 (5) 766-772;
  3. Sorensen, R G

    1. You have access
      Rat brain dendrotoxin receptors associated with voltage-gated potassium channels: dendrotoxin binding and receptor solubilization.
      R G Sorensen and M P Blaustein
      Molecular Pharmacology November 1989, 36 (5) 689-698;
  4. Spiegel, A

    1. You have access
      Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;
  5. Stegeman, J J

    1. You have access
      Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart.
      J J Stegeman, M R Miller and D E Hinton
      Molecular Pharmacology November 1989, 36 (5) 723-729;
  6. Stewart, J

    1. You have access
      Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
      V S Goldmacher, W A Blättler, J M Lambert, G McIntyre and J Stewart
      Molecular Pharmacology November 1989, 36 (5) 818-822;
  7. Stiles, G L

    1. You have access
      Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
      J P Longabaugh, J Didsbury, A Spiegel and G L Stiles
      Molecular Pharmacology November 1989, 36 (5) 681-688;
  8. Sumizawa, T

    1. You have access
      Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;

T

  1. Tahara, Y

    1. You have access
      Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;
  2. Thompson, D

    1. You have access
      Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates.
      D Thompson and T Eling
      Molecular Pharmacology November 1989, 36 (5) 809-817;

U

  1. Ullman, B

    1. You have access
      Adenosine is required for ethanol-induced heterologous desensitization.
      L E Nagy, I Diamond, K Collier, L Lopez, B Ullman and A S Gordon
      Molecular Pharmacology November 1989, 36 (5) 744-748;

W

  1. Weill, C L

    1. You have access
      Chronic clonazepam administration decreases gamma-aminobutyric acidA receptor function in cultured cortical neurons.
      L G Miller, R B Roy and C L Weill
      Molecular Pharmacology November 1989, 36 (5) 796-802;
  2. Wolfe, B B

    1. You have access
      Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
      W Lee and B B Wolfe
      Molecular Pharmacology November 1989, 36 (5) 749-757;

Y

  1. Yamazoe, Y

    1. You have access
      Suppression of hepatic levels of an ethanol-inducible P-450DM/j by growth hormone: relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes.
      Y Yamazoe, N Murayama, M Shimada, S Imaoka, Y Funae and R Kato
      Molecular Pharmacology November 1989, 36 (5) 716-722;
  2. Yoshimura, A

    1. You have access
      Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
      S Akiyama, A Yoshimura, H Kikuchi, T Sumizawa, M Kuwano and Y Tahara
      Molecular Pharmacology November 1989, 36 (5) 730-735;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 36, Issue 5
1 Nov 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics